Phibro Animal Health Corporation
PAHC Healthcare Drug Manufacturers Specialty & Generic
Phibro Animal Health Corporation’s revenue for fiscal 2026 (year ended June 2026) was $1.5 billion, up 17.1% from fiscal 2025. In the quarter to June 2026, revenue grew 4.77%, EPS grew 28.6%, free cash flow fell 35.7% and total debt rose 1.96%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.
Follow PAHC
A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Net Income |
+8 more TTM periods Free account |
67.82 | 92.09 | 95.23 | 99.72 |
Depreciation & Amortization |
51.65 | 53.04 | 52.87 | 53.83 | |
Non Cash Items (Other) |
14.40 | 12.41 | 17.62 | 10.50 | |
Accounts Receivable Change |
(53.05) | (15.73) | (17.03) | (7.49) | |
Change in inventories |
(65.31) | (93.11) | (98.70) | (86.34) | |
Accounts Payable Change |
39.62 | 27.07 | (4.20) | (12.46) | |
Change in payables and accrued liability |
37.00 | 23.25 | 23.81 | 26.35 | |
Change in other assets and liabilities |
(15.32) | (5.94) | (3.47) | (15.15) | |
Operating Cash Flow |
76.80 | 93.08 | 66.13 | 68.95 | |
Capital expenditures |
(42.52) | (45.79) | (53.36) | (59.09) | |
Short Term Investments Change (Net) |
25.50 | (19.02) | (12.52) | (11.57) | |
Other investing activities |
(3.22) | (2.97) | (1.50) | (0.79) | |
Investing cash flow |
(306.77) | (63.48) | (62.04) | (71.45) | |
Repayment/Issuance of Debt (Net) |
271.94 | (23.25) | 6.75 | 12.75 | |
Dividends Paid (Total) |
(19.45) | (19.46) | (19.46) | (19.46) | |
Other financial activities |
0.18 | 0.07 | 0.00 | 0.15 | |
Financing cash flow |
252.67 | (42.63) | (12.71) | (6.56) | |
Exchange Rate Adjustment |
(1.77) | 1.45 | 3.19 | 2.44 | |
Change in Cash |
20.93 | (11.59) | (5.42) | (6.62) | |
Beginning Cash |
68.04 | 68.04 | 68.04 | 68.04 | |
Ending Cash |
88.97 | 56.45 | 62.61 | 61.42 | |
Stock Based Compensation |
0.88 | 1.13 | 1.36 | 1.60 | |
Dividends Paid (Common) |
(19.45) | (19.46) | (19.46) | (19.46) | |
Assets Liabilities Change (Total) |
(57.06) | (64.45) | (99.59) | (95.10) | |
Investments Change (Net) |
25.50 | (19.02) | (12.52) | (11.57) |